Becton Dickinson & Co (BDX): Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2008-09-30, 2010-09-30, 2020-09-30 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$21.84B
Year ended 2025-09-30
+5.0%
3-year compound annual growth
+6.3%
5-year compound annual growth
2007-09-30: $6.28B2008-09-30: $6.90B2009-09-30: $6.99B2010-09-30: $7.12B2011-09-30: $7.58B2012-09-30: $7.71B2013-09-30: $8.05B2014-09-30: $8.45B2015-09-30: $10.28B2016-09-30: $12.48B2017-09-30: $12.09B2018-09-30: $15.98B2019-09-30: $17.29B2020-09-30: $16.07B2021-09-30: $19.13B2022-09-30: $18.87B2023-09-30: $19.37B2024-09-30: $20.18B2025-09-30: $21.84B$21.84B
2007-09-30 Revenue (USD) 2025-09-30
Period endedRevenueChange YoYSource filing
2025-09-30$21.84B+8.2%2025-11-25, From 2024-10-01
2024-09-30$20.18B+4.2%2025-11-25, From 2023-10-01
2023-09-30$19.37B+2.7%2025-11-25, From 2022-10-01
2022-09-30$18.87B-1.4%2024-11-27, From 2021-10-01
2021-09-30$19.13B+19.0%2023-11-21, From 2020-10-01
2020-09-30$16.07Bn/c2022-11-22, From 2019-10-01
2019-09-30$17.29B+8.2%2021-11-24, From 2018-10-01
2018-09-30$15.98B+32.2%2020-11-25, From 2017-10-01
2017-09-30$12.09B-3.1%2019-11-27, From 2016-10-01
2016-09-30$12.48B+21.4%2018-11-21, From 2015-10-01
2015-09-30$10.28B+21.7%2017-11-22, From 2014-10-01
2014-09-30$8.45B+4.9%2016-11-23, From 2013-10-01
2013-09-30$8.05B+4.5%2015-11-25, From 2012-10-01
2012-09-30$7.71B+1.6%2014-11-26, From 2011-10-01
2011-09-30$7.58B+6.5%2013-11-27, From 2010-10-01
2010-09-30$7.12Bn/c2012-11-21, From 2009-10-01
2009-09-30$6.99B+1.3%2011-11-23, From 2008-10-01
2008-09-30$6.90Bn/c2010-11-24, From 2007-10-01
2007-09-30$6.28Bn/a2010-01-21, From 2006-10-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Becton Dickinson & Co (BDX)2025-09-30$21.84B+8.2%
Boston Scientific Corp (BSX)2025-12-31$20.07B+19.9%
3M Co (MMM)2025-12-31$24.95B+1.5%
Stryker Corp (SYK)2025-12-31$25.12B+11.2%
Medline Inc. (MDLN)2025-12-31$28.43B+11.5%
Baxter International Inc (BAX)2025-12-31$11.24B+5.7%
Solventum Corp (SOLV)2025-12-31$8.32B+0.9%
ResMed Inc (RMD)2026-06-30$5.65B+9.9%
Dexcom Inc (DXCM)2025-12-31$4.66B+15.6%

Compare BDX, BSX, MMM, SYK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗